[1] GRAVALLESE E M, FIRESTEIN G S, KOSCAL N, et al. What is rheumatoid arthritis?[J]. N Engl J Med, 2024,390(13):e32.
[2] WINTHROP K L, PARK S H, GUL A, et al. Tuberculosis and other opportunistic infections in tofacitinib-treated patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2016, 75(6): 1133-1138.
[3] ZHANG Q, DONG X, ZHANG P, et al. Rheumatoid arthritis and tuberculosis[J]. Int J Rheum Dis, 2025, 28(3): e70090.
[4] CARMONA L, HERNÁNDEZ-GARCÍA C, VADILLO C, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis[J]. J Rheumatol, 2003, 30(7): 1436-1439.
[5] CHOI H, EUN Y, HAN K, et al. Impact of seropositivity and disease-modifying antirheumatic drugs on pulmonary tuberculosis risk in rheumatoid arthritis[J]. ERJ Open Res, 2025, 11(3):00957-2024.
[6] 潘晓梅, 马祖文, 刘婕妤, 等. 阿达木单抗辅助治疗类风湿关节炎的效果[J]. 中外医药研究, 2024, 3(22): 30-32.
[7] 杨茜妍. 类风湿关节炎合并症现况调查及结核发生风险因素分析[D]. 长沙: 中南大学, 2022.
[8] RAHAL A, ANDREO A, LE GALLOU F, et al. Enterobacter cloacae complex outbreak in a neonatal intensive care unit: multifaceted investigations and preventive measures are needed[J]. J Hosp Infect, 2021, 116: 87-90.
[9] 吴霜, 叶韦玮, 涂俊才, 等. 肺结核并发肺部感染病原菌及其耐药性[J]. 中华医院感染学杂志, 2021, 31(8): 1165-1168.
[10] YU J, LV X, WANG Q, et al. Metagenomic sequencing for identification of nontuberculous mycobacteria and other pathogens in patients with mixed infection of the lung[J]. Front Cell Infect Microbiol, 2025, 15:1592216. |
